APA

Lin Z., Ma M., Li H., Qi Q., Liu Y., Yan Y., Shen Y., Yang X., Zhu F., He S., Tang W. & Zuo J. (20190122). Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17. : Pharmacological research.

Chicago

Lin Ze-Min, Ma Meng, Li Heng, Qi Qing, Liu Yu-Ting, Yan Yu-Xi, Shen Yun-Fu, Yang Xiao-Qian, Zhu Feng-Hua, He Shi-Jun, Tang Wei and Zuo Jian-Ping. 20190122. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17. : Pharmacological research.

Harvard

Lin Z., Ma M., Li H., Qi Q., Liu Y., Yan Y., Shen Y., Yang X., Zhu F., He S., Tang W. and Zuo J. (20190122). Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17. : Pharmacological research.

MLA

Lin Ze-Min, Ma Meng, Li Heng, Qi Qing, Liu Yu-Ting, Yan Yu-Xi, Shen Yun-Fu, Yang Xiao-Qian, Zhu Feng-Hua, He Shi-Jun, Tang Wei and Zuo Jian-Ping. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17. : Pharmacological research. 20190122.